CHINARES PHARMA (03320) saw its shares decline more than 5% during the morning trading session. As of the time of writing, the stock was down 5.54%, trading at HK$5.46, with a turnover of HK$89.606 million. The movement follows the release of first-quarter financial results by several of its listed pharmaceutical subsidiaries. Among them, China Resources Sanjiu reported a 15.29% year-on-year decrease in its first-quarter net profit attributable to shareholders. Tasly Pharmaceutical Group posted a net profit of 370 million yuan, representing a 17.8% increase from the same period last year. Dong-E-E-Jiao announced a net profit of 455 million yuan, up 7.14% year-on-year. Notably, Kpc Pharmaceuticals,Inc. (600422) reported first-quarter revenue of 836 million yuan, a sharp decline of 48.01% year-on-year, falling back to levels seen a decade ago. The company recorded a net loss attributable to shareholders of 142 million yuan, marking its first first-quarter loss in two decades.